EntryPoint Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$331K	Sell	630 -23	-4%	-$12.1K	0.17%	237
2025 Q1	$414K	Buy	653 +190	+41%	+$121K	0.19%	174
2024 Q4	$330K	Buy	+463	New	+$330K	0.14%	316
2024 Q1	–	Sell	-69	Closed	-$60.6K	–	1696
2023 Q4	$60.6K	Buy	+69	New	+$60.6K	0.06%	629